TorMagnus Pharmaceuticals Company

TorMagnus Pharmaceuticals is a drug discovery firm dedicated to discovering treatments for Peroxisomal disorders.


Investors

Founded Date: 2022-05-01
Investor Type: contact@tormagnuspharma.com
Total Funding: 500000.0
Investors Number: 1.0
Last Funding Type: Pre-Seed
Industry: Medical BioTech
Technology: ['BioTech & HealthTech']
Headquarters: San Francisco, California, United States
Funding Status: Seed
Last Funding Date: 2023-04-05